In the liver, obesity is often manifested by the clinical disorder of the Non-Alcoholic Fatty Liver Disease (NAFLD). A proportion of NAFLD patients develop hepatic inflammation, known as Non-Alcoholic Steatohepatitis (NASH), which can end up in cirrhosis, or Hepatocellular Carcinoma (HCC). In this scenario, partial hepatectomy (PH) is an alternative to promote liver regeneration. However, as liver regeneration is impaired in NASH patients, more knowledge about its metabolic condition is needed to improve the regenerative response of the liver in this pathological condition. Although extensively employed, the panoply of molecular alterations involved in the regenerative response of the liver after partial hepatectomy PH is far from being ful...
Nonalcoholic fatty liver disease (NAFLD) is a consequence of defects in diverse metabolic pathways t...
Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unc...
Obesity frequently leads to insulin resistance and the development of hepatic steatosis. To characte...
The emergent discipline of metabolomics has attracted considerable research effort in hepatology. He...
The pathological mechanisms that distinguish simple steatosis from steatohepatitis (or NASH, with co...
The pathological mechanisms that distinguish simple steatosis from steatohepatitis (or NASH, with co...
Abstract Surgical resection remains a critical treatment option for many patients with primary and s...
Abstract Surgical resection remains a critical treatment option for many patients with primary and s...
In this study, liquid chromatography/quadrupole time of flight mass spectrometry (LC/QTOFMS) was em-...
Nonalcoholic fatty liver disease (NAFLD) encompasses nonalcoholic steatohepatitis (NASH) and affects...
The pathophysiology of nonalcoholic fatty liver disease (NAFLD) is a complex process involving metab...
Objectives—Non-alcoholic fatty liver disease (NAFLD) describes a spectrum of disorders including sim...
Obesity frequently leads to insulin resistance and the development of hepatic steatosis. to characte...
<div><p>Aim</p><p>Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A met...
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder in...
Nonalcoholic fatty liver disease (NAFLD) is a consequence of defects in diverse metabolic pathways t...
Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unc...
Obesity frequently leads to insulin resistance and the development of hepatic steatosis. To characte...
The emergent discipline of metabolomics has attracted considerable research effort in hepatology. He...
The pathological mechanisms that distinguish simple steatosis from steatohepatitis (or NASH, with co...
The pathological mechanisms that distinguish simple steatosis from steatohepatitis (or NASH, with co...
Abstract Surgical resection remains a critical treatment option for many patients with primary and s...
Abstract Surgical resection remains a critical treatment option for many patients with primary and s...
In this study, liquid chromatography/quadrupole time of flight mass spectrometry (LC/QTOFMS) was em-...
Nonalcoholic fatty liver disease (NAFLD) encompasses nonalcoholic steatohepatitis (NASH) and affects...
The pathophysiology of nonalcoholic fatty liver disease (NAFLD) is a complex process involving metab...
Objectives—Non-alcoholic fatty liver disease (NAFLD) describes a spectrum of disorders including sim...
Obesity frequently leads to insulin resistance and the development of hepatic steatosis. to characte...
<div><p>Aim</p><p>Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A met...
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder in...
Nonalcoholic fatty liver disease (NAFLD) is a consequence of defects in diverse metabolic pathways t...
Nonalcoholic fatty liver disease (NAFLD) in non-obese patients remains a clinical condition with unc...
Obesity frequently leads to insulin resistance and the development of hepatic steatosis. To characte...